BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3083146)

  • 21. [Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer].
    Sasaki T; Ota K; Ibayashi J; Sakata Y; Matsuoka T; Ishikawa M; Wakui A; Ogoshi K; Akazawa S; Sakai Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2545-55. PubMed ID: 2673045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Koike A; Takagi H
    J Surg Oncol; 1996 May; 62(1):4-9. PubMed ID: 8618399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
    Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical trial of carmofur (HCFU) in the treatment of malignant ovarian cancer--The first report: combination therapy with endoxan, mitomycin C, and toyomycin].
    Noda T; Kosakai H; Tsujimura K; Nakanishi A; Shintani M; Kamamoto Y; Shimamoto I; Ichijo M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1972-9. PubMed ID: 6412635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
    Chang HM; Jung KH; Kim TY; Kim WS; Yang HK; Lee KU; Choe KJ; Heo DS; Bang YJ; Kim NK
    Ann Oncol; 2002 Nov; 13(11):1779-85. PubMed ID: 12419751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Present status of surgical adjuvant chemotherapy of gastric cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2169-72. PubMed ID: 2500066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
    Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
    Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Outcome of adjuvant mifurol chemotherapy in patients with resected colonic carcinoma].
    Morioka Y; Muto T; Kusama S; Kimura T; Tomiyama J; Ogawa N
    Gan No Rinsho; 1989 Aug; 35(9):1031-41. PubMed ID: 2504972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
    Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer (the second report)--a randomized controlled study].
    Furue H; Uchino H; Orita K; Kimura T; Goto Y; Kondo T; Sato S; Takino T; Taguchi T; Nakao I
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1272-7. PubMed ID: 3159346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
    Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection.
    Maehara Y; Moriguchi S; Sakaguchi Y; Emi Y; Kohnoe S; Tsujitani S; Sugimachi K
    J Surg Oncol; 1990 Nov; 45(3):169-72. PubMed ID: 2122131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial.
    Allum WH; Hallissey MT; Kelly KA
    Lancet; 1989 Mar; 1(8638):571-4. PubMed ID: 2564109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neo-adjuvant chemotherapy with carmofur for colorectal cancer--a multi-institutional randomized controlled study].
    Kotake K; Koyama Y; Shida S; Tajima Y; Ishikawa H; Kanazawa K; Miyata M; Nagamachi Y; Iwasaki Y; Omoto R; Tamakuma S; Kitajima M; Kodaira S;
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1917-24. PubMed ID: 12465390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
    Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
    [No Abstract]   [Full Text] [Related]  

  • 38. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
    Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
    Jpn J Surg; 1988 Nov; 18(6):681-6. PubMed ID: 3150019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
    Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
    Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
    Coombes RC; Schein PS; Chilvers CE; Wils J; Beretta G; Bliss JM; Rutten A; Amadori D; Cortes-Funes H; Villar-Grimalt A
    J Clin Oncol; 1990 Aug; 8(8):1362-9. PubMed ID: 2199622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.